BCMA 抗体
(Tumor Necrosis Factor Receptor Superfamily, Member 17 (TNFRSF17))
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in mature B lymphocytes, and may be important for B cell development and autoimmune response. This receptor has been shown to specifically bind to the tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B/TALL-1/BAFF), and to lead to NF-kappaB and MAPK8/JNK activation. This receptor also binds to various TRAF family members, and thus may transduce signals for cell survival and proliferation. [provided by RefSeq, Jul 2008].
Recommended next Filters:
133 results
TNFRSF17
适用: 人
IHC
宿主: 兔
Monoclonal
RM526
unconjugated
Recombinant Antibody
Latest Publications for our BCMA 抗体
: "Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells." in: Haematologica, (2019) (PubMed).
: "Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma. ..." in: JCI insight, Vol. 3, Issue 8, (2018) (PubMed).
: "Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma." in: Oncotarget, Vol. 9, Issue 40, pp. 25764-25780, (2018) (PubMed).
: "Clinical relevance of circulating anti-ENA and anti-dsDNA secreting cells from SLE patients and their dependence on STAT-3 activation." in: European journal of immunology, Vol. 47, Issue 7, pp. 1211-1219, (2017) (PubMed).
: "The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells." in: Leukemia, Vol. 30, Issue 1, pp. 163-72, (2016) (PubMed).
: "PD-L1hi B cells are critical regulators of humoral immunity." in: Nature communications, Vol. 6, pp. 5997, (2015) (PubMed).
: "Robust isolation of malignant plasma cells in multiple myeloma." in: Blood, Vol. 123, Issue 9, pp. 1336-40, (2014) (PubMed).
: "Impaired B cell receptor signaling is responsible for reduced TACI expression and function in X-linked immunodeficient mice." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 8, pp. 3582-95, (2014) (PubMed).
: "Transcription elongation factor ELL2 drives Ig secretory-specific mRNA production and the unfolded protein response." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 193, Issue 9, pp. 4663-74, (2014) (PubMed).
: "B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 19, Issue 8, pp. 2048-60, (2013) (PubMed).
: "Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma. ..." in: JCI insight, Vol. 3, Issue 8, (2018) (PubMed).
: "Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma." in: Oncotarget, Vol. 9, Issue 40, pp. 25764-25780, (2018) (PubMed).
: "Clinical relevance of circulating anti-ENA and anti-dsDNA secreting cells from SLE patients and their dependence on STAT-3 activation." in: European journal of immunology, Vol. 47, Issue 7, pp. 1211-1219, (2017) (PubMed).
: "The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells." in: Leukemia, Vol. 30, Issue 1, pp. 163-72, (2016) (PubMed).
: "PD-L1hi B cells are critical regulators of humoral immunity." in: Nature communications, Vol. 6, pp. 5997, (2015) (PubMed).
: "Robust isolation of malignant plasma cells in multiple myeloma." in: Blood, Vol. 123, Issue 9, pp. 1336-40, (2014) (PubMed).
: "Impaired B cell receptor signaling is responsible for reduced TACI expression and function in X-linked immunodeficient mice." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 8, pp. 3582-95, (2014) (PubMed).
: "Transcription elongation factor ELL2 drives Ig secretory-specific mRNA production and the unfolded protein response." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 193, Issue 9, pp. 4663-74, (2014) (PubMed).
: "B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 19, Issue 8, pp. 2048-60, (2013) (PubMed).
Aliases for BCMA 抗体
TNF receptor superfamily member 17 (Tnfrsf17) 抗体TNF receptor superfamily member 17 (TNFRSF17) 抗体
tumor necrosis factor receptor superfamily, member 17 (Tnfrsf17) 抗体
BCM 抗体
BCMA 抗体
CD269 抗体
Tnfrsf13 抗体
TNFRSF13A 抗体
Tnfrsf13a 抗体
TNFRSF17 抗体
您还需要查找其他产品吗？
You are here:
